Literature DB >> 10685140

A concise review of the cost-effectiveness of coronary heart disease prevention.

A I Brown1, A M Garber.   

Abstract

Coronary heart disease is one of the largest sources of morbidity, mortality, and health care expenditure in the United States. This article reviews a number of studies that estimate the cost per unit of health benefits associated with different primary and secondary prevention strategies for coronary heart disease. Although prevention does not provide a panacea for rising health care spending, many preventive strategies are cost-effective when compared to other common clinical interventions. Prevention should be incorporated into regular clinical practice.

Entities:  

Mesh:

Year:  2000        PMID: 10685140     DOI: 10.1016/s0025-7125(05)70219-4

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  3 in total

Review 1.  Cost per millimeter of mercury lowering is a measure of economic value for antihypertensive agents.

Authors:  R S Chen; P Lapuerta
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

2.  [Cost-effectiveness of prevention of coronary disease in Germany].

Authors:  K W Lauterbach; A Gerber; G Klever-Deichert; B Stollenwerk
Journal:  Z Kardiol       Date:  2005

3.  Cost implications of improving blood pressure management among U.S. adults.

Authors:  Teryl K Nuckols; Julia E Aledort; John Adams; Julie Lai; Myong-Hyun Go; Joan Keesey; Elizabeth McGlynn
Journal:  Health Serv Res       Date:  2011-02-09       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.